HYTN Announces Proposed Spin-Out of BPC-157 Peptide Drug Development Business
VANCOUVER, British Columbia, April 23, 2026 (GLOBE NEWSWIRE) — HYTN Innovations Inc. (CSE: HYTN) (OTC Pink: HYTNF) (FSE: 85W0) (“HYTN” or the “Company”) announces that its Board of Directors has approved the spin-out of an internally developed peptide drug development business into a dedicated new company (“SpinCo”). As part of the proposed spin-out, SpinCo is […]
Original Source
Read the full article at Financialpost →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.